JAK-IN-35
JAK-IN-35 (compound TG46) is a JAK2 inhibitor that canb be used in cancer research[1].
Product Specifications
CAS Number
936091-15-5
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/jak-in-35.html
Purity
99.30
Solubility
10 mM in DMSO
Smiles
O=S(C1=CC=CC(NC2=NC(NC3=CC=C(CN4CCOCC4)C=C3)=NC=C2C)=C1)(NC(C)(C)C)=O
Molecular Formula
C26H34N6O3S
Molecular Weight
510.65
References & Citations
[1]Wenge Zhu, et al. Combination therapy for treating cancer. Patent WO2018187485A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
